2020
Ponatinib Treatment in CML and Ph+ all patients: real-life data from the Czech registries.
KORIŤÁKOVÁ, E., Michael DOUBEK, E. FABER, T. SZOTKOWSKI, E. CMUNT et. al.Basic information
Original name
Ponatinib Treatment in CML and Ph+ all patients: real-life data from the Czech registries.
Authors
KORIŤÁKOVÁ, E., Michael DOUBEK, E. FABER, T. SZOTKOWSKI, E. CMUNT, J. HORÁČEK, P. BĚLOHLÁVKOVÁ, P. JINDRA, L. STEJSKAL, Z. KOŘÍSTEK, H. KLAMOVÁ, C. ŠÁLEK, František FOLBER, R. KELLNEROVÁ, M. CHRÁPAVÁ and Daniela ŽÁČKOVÁ
Edition
Pražské hematologické dny, Praha, sb. abstrakt, s.130-1, 2020
Other information
Type of outcome
Conference abstract
Confidentiality degree
is not subject to a state or trade secret
Organization unit
Faculty of Medicine
Changed: 10/2/2021 11:30, Jitka Firešová